Morgan Stanley Raises China Humanoid Robot Shipment Forecasts
0xBroomberg
Morgan Stanley nearly doubled its 2026 China humanoid-robot shipment forecast from 28,000 to 50,000 units, projecting 446,000 units by 2030. This means Wall Street is repricing humanoid robots from a concept play to a mass-production story.
Why raise the forecast by nearly 80% in one go?
Morgan Stanley cites three drivers: stronger policy support, positive supply-chain feedback loops, and advancing commercialization milestones.
A growing number of Chinese firms now target late 2026 as their mass-production start date. This means → the industry has moved past trade-show prototypes to concrete production-line timelines.
In plain terms = government funding, cheaper components, and real customer orders are landing at the same time — that is why the shipment estimate jumped nearly 80% in a single revision.
Will prices keep falling?
Morgan Stanley expects overall costs to keep declining, but forecasts a modest uptick in average selling prices during 2027–2028.
The reason is not price hikes on existing models. Higher adoption of full-size, premium humanoid robots will push the blended ASP upward. In plain terms = the same robot is not getting more expensive — the expensive tier is selling more units.
After that, prices are expected to resume their downtrend toward the end of the decade. This reflects scale economics eventually overpowering the product-mix shift.
Why does Q3 this year matter?
Morgan Stanley flags Q3 2025 as a critical window and names two potential catalysts.
First, a possible unveiling of Tesla's Optimus Gen 3. This means → a benchmark product refresh that could reset market attention and valuation anchors across the entire sector.
Second, planned IPOs by several Chinese humanoid-robot makers. In plain terms = once a company lists, the capital market gains a tradable, priceable proxy for the sector — amplifying momentum further.
Content is for reference only, not financial advice.